Valeria CONTI | PHARMACOLOGY

cod. 1060200019

PHARMACOLOGY

	1060200019
	DEPARTMENT OF MEDICINE, SURGERY AND DENTISTRY "SALERNITANA MEDICAL SCHOOL"
	EQF7
	DENTISTRY
	2024/2025

PERCORSO COMUNE

	OBBLIGATORIO
	YEAR OF COURSE 3
	YEAR OF DIDACTIC SYSTEM 2023
	FULL ACADEMIC YEAR

TEACHING UNITS

	SSD	CFU	HOURS	ACTIVITY	TYPE OF ACTIVITY
	BIO/14	8	88	LESSONS	COMPULSORY SUBJECTS, CHARACTERISTIC OF THE CLASS

PROFESSORS

	AMELIA FILIPPELLI T Curriculum
	VALERIA CONTI Curriculum

	Objectives
	THE COURSE AIMS TO PROVIDE KNOWLEDGE ON THE GENERAL MECHANISMS OF PHARMACODYNAMICS, PHARMACOKINETICS, SYNAPTIC TRANSMISSIONS, MOLECULAR PHARMACOLOGY, DRUG RESEARCH AND DEVELOPMENT, ADVERSE DRUGS REACTION AND PHARMACOLOGICAL INTERACTIONS, CLINICAL USES, DOSAGE AND SIDE EFFECTS OF DRUGS ACTIVE IN THE TREATMENT OF THE MAIN ORGAN AND SYSTEM PATHOLOGIES, PHARMACOSURVEILLANCE, GENDER MEDICINE AND PHARMACOGENETICS. KNOWLEDGE AND UNDERSTANDING - FUNDAMENTALS OF PHARMACOLOGY AND THE USE OF THE MAIN CLASSES OF DRUGS USED IN MEDICAL PRACTICE. - GENERAL KNOWLEDGE ON THE MAIN CLASSES OF DRUGS, ON THEIR PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS, ON THE RATIONALE FOR THEIR THERAPEUTIC USE AND ON POSSIBLE SIDE EFFECTS APPLYING KNOWLEDGE AND UNDERSTANDING - ABILITY TO DEFINE THE RATIONAL BASES TO CORRECTLY CHOOSE AND USE THE DRUGS ACCORDING TO THE PATHOLOGICAL CONTEXTS, THE STATE OF HEALTH OF PATIENTS AND THE SCIENTIFIC EVIDENCE - ABILITY TO MONITOR THE EFFECTIVENESS OF THERAPY AND TO RECOGNIZE THE POSSIBLE ADVERSE EFFECTS. -ABILITY TO IDENTIFY AND CORRECTLY RESOLVE THE COMPLEX PROBLEMS RELATED TO THE USE OF DRUGS IN CLINICAL PRACTICE (POLYPHERAPY, DRUG INTERACTIONS, BIOEQUIVALENT USE) DEMONSTRATING AUTONOMY OF JUDGMENT, LEARNING SKILLS AND COMMUNICATION

THE COURSE AIMS TO PROVIDE KNOWLEDGE ON THE GENERAL MECHANISMS OF PHARMACODYNAMICS, PHARMACOKINETICS, SYNAPTIC TRANSMISSIONS, MOLECULAR PHARMACOLOGY, DRUG RESEARCH AND DEVELOPMENT, ADVERSE DRUGS REACTION AND PHARMACOLOGICAL INTERACTIONS, CLINICAL USES, DOSAGE AND SIDE EFFECTS OF DRUGS ACTIVE IN THE TREATMENT OF THE MAIN ORGAN AND SYSTEM PATHOLOGIES, PHARMACOSURVEILLANCE, GENDER MEDICINE AND PHARMACOGENETICS.

KNOWLEDGE AND UNDERSTANDING
- FUNDAMENTALS OF PHARMACOLOGY AND THE USE OF THE MAIN CLASSES OF DRUGS USED IN MEDICAL PRACTICE.
- GENERAL KNOWLEDGE ON THE MAIN CLASSES OF DRUGS, ON THEIR PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS, ON THE RATIONALE FOR THEIR THERAPEUTIC USE AND ON POSSIBLE SIDE EFFECTS

APPLYING KNOWLEDGE AND UNDERSTANDING
- ABILITY TO DEFINE THE RATIONAL BASES TO CORRECTLY CHOOSE AND USE THE DRUGS ACCORDING TO THE PATHOLOGICAL CONTEXTS, THE STATE OF HEALTH OF PATIENTS AND THE SCIENTIFIC EVIDENCE
- ABILITY TO MONITOR THE EFFECTIVENESS OF THERAPY AND TO RECOGNIZE THE POSSIBLE ADVERSE EFFECTS.
-ABILITY TO IDENTIFY AND CORRECTLY RESOLVE THE COMPLEX PROBLEMS RELATED TO THE USE OF DRUGS IN CLINICAL PRACTICE (POLYPHERAPY, DRUG INTERACTIONS, BIOEQUIVALENT USE) DEMONSTRATING AUTONOMY OF JUDGMENT, LEARNING SKILLS AND COMMUNICATION

	Prerequisites
	PROPAEDEUTICITY ACCORDING TO SECTION 11 OF THE PUBLISHED DIDACTIC GUIDELINES

	Contents
	THE FOLLOWING TOPICS WILL BE COVERED DURING THE COURSE: PHARMACODYNAMICS. PRINCIPLES OF BIOLOGICAL ASSAY. RESEARCH AND DRUG DEVELOPMENT. PHARMACOKINETICS. MOLECULAR PHARMACOLOGY. DRUGS ACTING ON THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS. INFLAMMATION, IMMUNOMODULATION AND HEMATOPOIESIS. DRUGS AFFECTING GASTROINTESTINAL FUNCTION. DRUGS TO TREAT PAIN AND MUSCULOSKELETAL DISORDERS. CHEMOTHERAPY OF MICROBIAL AND NEOPLASTIC DISEASES; DRUG ADDICTION; PRINCIPLES OF TOXICOLOGY. DRUGS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND METABOLISM

Contents

THE FOLLOWING TOPICS WILL BE COVERED DURING THE COURSE: PHARMACODYNAMICS. PRINCIPLES OF BIOLOGICAL ASSAY. RESEARCH AND DRUG DEVELOPMENT. PHARMACOKINETICS. MOLECULAR PHARMACOLOGY. DRUGS ACTING ON THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS. INFLAMMATION, IMMUNOMODULATION AND HEMATOPOIESIS. DRUGS AFFECTING GASTROINTESTINAL FUNCTION. DRUGS TO TREAT PAIN AND MUSCULOSKELETAL DISORDERS. CHEMOTHERAPY OF MICROBIAL AND NEOPLASTIC DISEASES; DRUG ADDICTION; PRINCIPLES OF TOXICOLOGY.

DRUGS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND METABOLISM

	Teaching Methods
	THE ATTENDANCE TO THE COURSE IS MANDATORY. IN ORDER TO TAKE THE FINAL EXAM, THE STUDENT MUST HAVE ATTENDED AT LEAST 75% OF THE TEACHING HOURS.

	Verification of learning
	ACHIEVEMENT OF THE OBJECTIVES IS VERIFIED BY PASSING THE FINAL EXAM. THE FINAL EXAM CONSISTS OF AN ORAL TEST. THE ORAL TEST INCLUDES AN INTERVIEW WITH QUESTIONS AND DISCUSSION FOR ABOUT 30 MINUTES. IT IS FINALIZED TO ENSURE THE LEVEL OF KNOWLEDGE AND UNDERSTANDING REACHED BY THE STUDENT ON THE TOPICS DEALED DURING THE LESSONS, AS WELL AS TO VERIFY THE ORAL EXPOSURE CAPACITY, BY USING THE APPROPRIATE TERMINOLOGY. EACH EXAM IS EVALUATED IN A THIRTIETH SCORE SCALE AND IS PASSED WITH A MINIMUM SCORE OF 18/30.

Verification of learning

ACHIEVEMENT OF THE OBJECTIVES IS VERIFIED BY PASSING THE FINAL EXAM. THE FINAL EXAM CONSISTS OF AN ORAL TEST. THE ORAL TEST INCLUDES AN INTERVIEW WITH QUESTIONS AND DISCUSSION FOR ABOUT 30 MINUTES.
IT IS FINALIZED TO ENSURE THE LEVEL OF KNOWLEDGE AND UNDERSTANDING REACHED BY THE STUDENT ON THE TOPICS DEALED DURING THE LESSONS, AS WELL AS TO VERIFY THE ORAL EXPOSURE CAPACITY, BY USING THE APPROPRIATE TERMINOLOGY. EACH EXAM IS EVALUATED IN A THIRTIETH SCORE SCALE AND IS PASSED WITH A MINIMUM SCORE OF 18/30.

	Texts
	GOODMAN & GILMAN'S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, 13TH EDITION, EDITED BY LAURENCE L. BRUNTON, RANDA HILAL-DANDAN, BJÖRN C. KNOLLMANN, 2017

	More Information
	COMPULSORY ATTENDANCE - MINIMUM PERCENTAGE 75% FURTHER INFORMATION CAN BE REQUESTED VIA E-MAIL: AFILIPPELLI@UNISA.IT

BETA VERSION Data source ESSE3 [Ultima Sincronizzazione: 2024-11-18]

Valeria CONTI | PHARMACOLOGY